ABST yields 1.74% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, ABST + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABST + JNJ for your $10,000?
Absolute Software Corporation develops, markets, and provides software services that support the management and security of computing devices, applications, data, and networks for various organizations. The company's Absolute platform offer Absolute Visibility that provides information on device hardware, software, and location; Absolute Control that provide remediation capabilities, such as the ability to remotely freeze devices and delete data; Absolute Resilience, which offer remote scripting, self-healing for critical apps, investigation and recovery services, and sensitive data identification; Absolute Ransomware Response that enables organizations to assess their ransomware preparedness for endpoints, monitors their endpoint cyber hygiene across the entire device fleet and allows for an expedited endpoint recovery; Absolute VPN an enterprise solution; Absolute ZTNA that protects networks and employees with real time risk analysis; and Absolute Insights for Network provides real-time data about device, application, and network performance in a single pane of glass. The company markets its solutions through device original equipment manufacturers, distributors, and value added resellers, as well as directly to healthcare organizations, educational institutions, governmental agencies, and individual consumers. It operates in North America, the United Kingdom, Vietnam, Germany, Australia, Japan, and Latin America. Absolute Software Corporation was incorporated in 1993 and is headquartered in Vancouver, Canada.
Full ABST Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.